Invention Grant
- Patent Title: Prodrug derivatives of substituted triazolopyridines
- Patent Title (中): 取代三唑并吡啶的前药衍生物
-
Application No.: US14897951Application Date: 2014-06-06
-
Publication No.: US09586958B2Publication Date: 2017-03-07
- Inventor: Volker Schulze , Hans-Georg Lerchen , Donald Bierer , Antje Margret Wengner , Gerhard Siemeister , Philip Lienau , Ursula Krenz , Dirk Kosemund , Detlef Stöckigt , Michael Brüning , Ulrich Lücking , Ildikó Terebesi
- Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
- Applicant Address: DE Berlin
- Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
- Current Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
- Current Assignee Address: DE Berlin
- Agency: Morrison & Foerster LLP
- Priority: EP13171508 20130611
- International Application: PCT/EP2014/061779 WO 20140606
- International Announcement: WO2014/198647 WO 20141218
- Main IPC: C07D471/02
- IPC: C07D471/02 ; C07D471/04 ; C07F9/6561 ; C07K5/062 ; C07K5/068 ; A61K38/00
Abstract:
The present invention relates to prodrug derivatives of Mps-1 kinase inhibitors, processes for their preparation, and their use for the treatment and/or prophylaxis of diseases.
Public/Granted literature
- US20160207915A1 PRODRUG DERIVATIVES OF SUBSTITUTED TRIAZOLOPYRIDINES Public/Granted day:2016-07-21
Information query
